Austin, Texas
XBiotech broke ground in September of 2014 on a 46,000-sf pharmaceutical research and manufacturing center in Austin, Texas. The $12 million facility will reach completion in mid-2015 with production of the cancer drug Xilonix commencing in early 2016. The project is part of a $200 million campus that XBiotech plans to develop on the 48-acre site.
